ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 492 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR The HPV Vaccine: Increasing the Use of an Important Cancer Prevention... December 20, 2018 Immunotherapy Plus Chemotherapy Helps People With Advanced Nasopharyngeal Cancer: The ASCO... April 18, 2022 How to Find an Oncologist Who’s an LGBTQ+ Ally: An Expert... April 14, 2021 EMA Recommends Granting a Marketing Authorisation for the Hybrid Medicine Imatinib July 29, 2021 Load more HOT NEWS FDA Approves Durvalumab for Muscle Invasive Bladder Cancer EMA Recommends Granting a Marketing Authorisation for Vimseltinib Data Collection Analysis Demonstrates Changes in Lung Cancer Management Throughout the... Volunteering with Pride: Brett’s award-winning involvement with Cancer Research UK
